Simonian Nancy A

Syros Pharmaceuticals, Inc. · Director

Simonian Nancy A is listed in filings as Director at Syros Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Dec 4, 2024, including sale activity. Recent filings connect the profile to Syros Pharmaceuticals, Inc. (SYRS). The current snapshot covers public activity from Nov 4, 2024 to Dec 4, 2024. Reported amounts are shown as $10.0K to $35.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceLast Price
Syros Pharmaceuticals, Inc.SYRS$36k134.7k sharesSellNov 25, 2024$0.2653$0.0001